Skip to main content

AHA: Percutaneous Coronary Intervention Significantly Cuts Angina Symptoms

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 17, 2023.

By Lori Solomon HealthDay Reporter

FRIDAY, Nov. 17, 2023 -- Percutaneous coronary intervention (PCI) improves symptoms versus placebo among patients with stable angina and taking no chest pain medication, according to a study published online Nov. 11 in the New England Journal of Medicine to coincide with the American Heart Association Scientific Sessions 2023, held from Nov. 11 to 13 in Philadelphia.

Christopher A. Rajkumar, M.B.B.S., from Imperial College London, and colleagues compared PCI versus placebo for angina relief in patients who were not receiving antianginal medication. The analysis included 301 patients randomly assigned to PCI or placebo with 12 weeks of follow-up.

The researchers found that at follow-up, the mean angina symptom score was 2.9 in the PCI group versus 5.6 in the placebo group (odds ratio, 2.21). Unacceptable angina occurred in one patient in the placebo group, resulting in unblinding. Four patients in the PCI group experienced acute coronary syndromes versus six patients in the placebo group.

"Going forward, patients and medical teams have a choice of two pathways for chest pain relief: chest pain medication or PCI," coauthor Rasha Al-Lamee, M.B.B.S., Ph.D., also from Imperial College London, said in a statement. "The key finding of this trial is that it is the first therapy initiated that seems to have the maximum effect. Although PCI is neither risk-free nor cost-free, its use as an upfront procedure can now be considered evidence-based."

The study was funded in part by Philips.

Abstract/Full Text (subscription or payment may be required)

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2023

Read this next

In-Hospital Mortality Rare After Percutaneous Coronary Intervention

MONDAY, April 15, 2024 -- In-hospital mortality is rare after percutaneous coronary intervention (PCI) and is most commonly related to prior cardiovascular condition, according to...

CAC Score Predicts MACE in Patients With Stable Chest Pain

THURSDAY, March 14, 2024 -- For people with stable chest pain referred for invasive coronary angiography (ICA), the risk for major adverse cardiovascular events (MACE) is low...

Ultrahigh Spatial-Resolution PCD CT Improves Assessment of Calcified Stenoses

TUESDAY, Feb. 27, 2024 -- Use of ultrahigh spatial-resolution photon-counting detector (PCD) computed tomography (CT) improves in vivo and in vitro coronary stenosis assessment...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.